Bone marrow graft for the treatment of autoimmune diseases;Les greifes de moelle dans le traitement des maladies auto-immunes

Presse Medicale

Volumn 28, Issue 27, 1999, Pages 1488-1494

  Farge, D ^a   Breban, M ^b   Guillevin, L ^b   Piette, J C ^b   Cabane, J ^b   Cherin, P ^b   Cosserat, J ^b   Sicard, D ^b   Ribaud, P ^b   Marolleau, J P ^b   Bouscary, D ^b   Mariette, X ^b   Gisselbrecht, Ch ^b   Gluckman, E ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; CYTOPENIA; HUMAN; LUPUS ERYTHEMATOSUS; MORTALITY; MYOSITIS; PERIPHERAL BLOOD STEM CELL; REVIEW; SCLERODERMA; STEM CELL TRANSPLANTATION; VASCULITIS; ALLOTRANSPLANTATION; AUTOTRANSPLANTATION; CLINICAL TRIAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MULTICENTER STUDY;

AUTOIMMUNE DISEASES; BONE MARROW TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033581252     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Medsger TA, Steen VA. ch 3 Classification, Prognosis in Systemic Sclerosis ch 3 page 51-64. Williams and Wilkins 1996 Clements PJ, Furst DE.
2. Guillevin L, Lhote F, Gayraud M et al. Pronostic factors in polyarteritis nodosa and Churg Strauss syndrome Medicine 1996 ; 75:17-28.
3. Luqmani R, Bacon P, Moots R et al. Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis activity score. Q J Med 1994 ; 87:671-8.
4. Hoffman GS, Kerr C, Leavit E et al. Wegener's granulomatosis : an analysis of 158 patients. Ann Int Med 1992 ; 116:488-98.
5. Arsura EI, Greenberg AS. Adverse impact of pulmonary fibrosis on prognosis in polymyositis and dermatopolymyosistis. Semin Arthritis Rheum 1988 ; 18:29-33.
6. Ciruelo E, de la Cruz J, Lopez I, Gomez-Reino JJ. Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide. Arthritis Rheum 1996 ; 39:2028-34.
7. Boumpas DT, Austin HA III, Vaughn EM et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 1992 ; 340:741-5.
8. Pincus T, Callahan LF. What is the natural history of rheumatoid arthritis ? Rheumatic Diseases Clinic of North America 1993 ; 19:123-51.
9. Ikehara S, Good RA, Nakamura T et al. Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci USA 1985 ; 82:2483-7.
10. RA Good, S Ikehara. Preclinical investigations that subserve efforts to employ bone marrow transplantation for rheumatoid or autoimmune diseases J Rheumatol 1997 ; 24:5-12.
11. Marmont AM. Immune ablation followed by allogenic or autologous bone marrow transplantation : a new treatment for severe autoimmune diseases ? Stem Cells 1994 ; 12:125-35.
12. Adachi Y, Inaba M, Amoh Y et al. Effect of bone marrow transplantation on anti-phospholipid antibody syndrome in murine lupus mice. Immunobiol 1995 ; 192:218-30.
13. Karussis DM, Vourka-Karussis U, Lehmann D, Abramasky O, Ben-Nun A. Immunomodulation of autoimmunity in MRL/Lpr mice with syngeneic bone marrow transplanatation (SBMT). Clin Exp Immunol 1995 ; 100:111-17.
14. Mizutani H, Engelman RW, Kinjoh K, Kurata Y, Ikehara S, Good RA. Prevention and induction of occlusive coronary vascular disease in autoimmune (W/B)F1, mice by haploidentical bone marrow transplantation : possible role for anticardiolipin autoantibodies. Blood 1993 ; 82:3091-7.
15. Nakagawa T, Nagata N, Hosaka N, Ogawa R, Nakamura K, Ikehara S. Prevention of autoimmune inflammatory polyarthritis in male New Zealand black/kn mice by transplantation of bone marrow cells plus bone (stromal cells). Arthritis Rheum 1993 ; 36:263-8.
16. Van Bekkum DW. Review : BMT in experimental auto-immune diseases. Bone Marrow Transplant 1993 ; 11:183-7.
17. Levite M, Zinger H, Zisman E, Reisner Y, Mozes E. Beneficial effects of bone marrow transplantation on the serological manifestations and kidney pathology of experimental systemic lupus erythematosus. Cell Immunol 1995 ; 162:138-45.
18. Nakamura T, Ikehara S, Good RA et al. Abnormal stem cells in autoimmune-prone mice are responsible for premature thymic involution. Thymus 1985 ; 7:151-60.
19. Georgiou HM, Slattery RM, Charlton B. Bone marrow transplantation prevents autoimmune diabetes in nono-bese diabetic mice. Transplant Proc 1993 ; 25:2896-7.
20. Breban M, Hammer RE, Richardson JA, Taurog JD. Transfer of the inflammatory disease of HLA-B27. Transgenic rats by bone marrow engraftment. J Exp Med 1993 ; 178:1607-16.
21. Breban M, Fernandez-Sueira JL, Richardson JA et al. T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J Immunol 1996 ; 156:794-803.
22. Knaan-Shanzer S, Houben P, Kinwel-Bohre EPM, Van Bekkum DW. Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant 1991 ; 8:333-8.
23. Van Gelder M, Kinwel-Bohre EPM, Van Bekkum DW. Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT. Bone Marrow Transplant 1993 ; 11:233-41.
24. Marmont AM. Autoimmunity and allogeneic bone marrow transplantation. Bone Morrow Transplant 1992 ; 9:1-3.
25. Smith CI, Aarli JA, Bibefeld P. Myasthenia gravis after bone marrow transplantation: evidence for a donor origin. N Engl J Med 1983 ; 309:1565-8.
26. Holland FJ, McConnon JK, Volpe R, Saunders EF. Concordant Graves's disease after bone marrow transplantation: implications for pathogenesis. J Clin Endocrinol Metab 1991 ; 72:837-40.
27. Aldouri MA, Ruggier R, Epstein O, Prentice HG. Adoptive transfer of hyperthyroidism and autoimmune thyroiditis after bone marrow transplantatation for chronic myeloid leukemia. Br J Hematol 1990 ; 74:118-20.
28. Vialettes B, Maraninchi DL, San Marco MP et al. Autoimmune polyendocrine failure-type I (insulin dependent) diabetes mellitus and hypothyroidism-after allogeneic bone marrow transplantation in a patient with lymphoblastic leukemia. Diabetologia 1993 ; 36:542-6.
29. JL Nelson, R Torrez, FM Iouie, OS Choe, R Storb, KM Sullivan. Pre-existing autoimmune disease in patients with longterm survival after allogeneic bone marrow transplantation. J Rheumatol 1997 ; 24:23-9.
30. Sivakumaran M, Hutchinson RM, Pringle H, Graham S, Primrose L, Wood JK. Thrombocytopenia following autologous bone marrow transplantation: evidence for autoimmune aetiology and B cell clonal involvement. Bone Marrow Transplant 1995 ; 15:531-6.
31. Baldwin JL, Storb B, Thomas ED, Mannik M. Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum 1977 ; 20:1043-8.
32. McKendry RJR, Huebsch L, Leclair B. Progression of rheumathoid arthritis following bone marrow transplantation: a case report with a 13 year follow up. Arthritis Rheum 1996 ; 39:1246-53.
33. Jacobs P, Vincent MD, Martelle RW. Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplanatation for drug induced aplastic anaemia. Bone Marrow Transplant 1986 ; 1:237-9.
34. Jowitt SN, Liu Yin JA. Psoriasis and bone marrow transplantation. Br Med J 1990 ; 300:1398-9.
35. Eedy DJ, Burrows D, Bridges JM, Jones FGC. Clearance of severe psoriasis after allogenic bone marrow transplantation. Br Med J 1990 ; 300:908-9.
36. Liu Yin JA, Jowitt SN. Resolution of immune mediated diseases following allogeneic bone marrow transplantation for leukaemia. Bone Marrow Transplant 1992 ; 9:31-3.
37. Marmont AM, Tyndall A, Gratwhol A, Vischer T. Hematopoietic precursor cell transplants for autoimmune diseases. Lancet 1995 ; 345:978.
38. Marmont AM. Stem cell transplantation for severe autoimmune disorders with special reference to rheumatic diseases. J Rheumatol 1997 ; 24:13-18.
39. Brooks PM. Hematopoietic stem cell transplantation for autoimmune diseases. J Rheumatol 1997 ; 24:19-22.
40. Marmont AM, Van Bekkum DW. Stem cell transplantation for severe autoimmune diseases : new proposals but still unanswered questions. Bone marrow transplant 1995 ; 16:497-8.
41. Slavin S. Treatment of life-threatening autoimmune diseases with myeloablative doses of immunosuppressive agents : experimental background and rationale for ABMT. Bone Marrow Transplant 1993 ; 12:85-8.
42. Tyndall A, Gratwohl A. Hematopoietic stem and progenitor cells in the treament of severe autoimmune diseases. Ann Rheum Dis 1996 ; 55:149.
43. Tyndall AG. What is the present clinical experience and who are the patients who may get some clinical benefits? European Congress of Bone Marrow Transplantation. Bone Marrow Transplant 1997 ; 19: no0830 p S208.
44. Ribaud P, Gluckman E. Greffe de moelle allogènique in Godeau P, Herson S, Piette JC Traité de Médecine, 3ème édition, p 2832-2835 Editeurs Médecine Sciences, Flammarion, Paris 1996.
45. M Territo. The use of autologous transplantation in the treatment of malignant disorders. J Rheumatol 1997 ; 24:36-40.
46. Appelbaum FR. Allogeneic stem cell transplantation for the treatment of hematologic malignancies : current indications and challenges. J Rheumatol 1997 ; 24:41-5.
47. Sullivan KM. Longterm followup and quality of life after hematopoietic stem cell transplantation. J Rheumatol 1997; 24 (48): 46-52.
48. Storb R. Hematopoietic stem cell transplantation in non malignant diseases. J Rheumatol 1997 ; 24:30-5.
49. «Le prélèvement et la greffe en France en 1996». Rapport du Conseil Médical et Scientifique de l'Etablissement Francais des Greffes.
50. McSweeney PA, Nash RA, Storb R, Furst DE, Gauthier J, Sullivan KM. Autologous stem cell transplantation for autoimmune diseases : issues in protocol development. J Rheumatol 1997 ; 24:79-84.
51. Burt RK, Burns W, Hess A. Bone marrow transplantation for multiple sclerosis. Bone Marrow Transplant 1995 ; 16:1-6.
52. Euler HH, Marmont AM, Bacigalupo A et al. Early recurrence or persistence of autoimmune disease after unmanipulated autologous stem cell transplantation. Blood 1996 ; 88:3621-5.
53. Lim SH, Kell J, Al-Sabah A, Bashi W, Balley-Wood R. Peripheral blood stem-cell transplantation for refractory auto-immune thrombocytopenic purpura. Lancet 1996 ; 349:475.
54. Burt RK, Trraynor A, Ramsey-Goldman R. Hematopoietic stem-cell transplantation for systemic lupus erythematous. N Engl J Med 1997 ; 337:1777-8.
55. Van de Putte LBA, Tyndall A, Van den Hoogen FJH, Smolen JS. Hematopoietic stem cell transplants for auto-immune disease : role of EULAR. J Rheumatol 1997 ; 24:98-9.